Breakdown | ||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
49.59M | 62.63M | 37.34M | 25.46M | 18.35M | Gross Profit |
2.81M | 12.20M | 9.06M | 10.23M | 6.76M | EBIT |
-108.93M | -106.38M | -75.60M | -51.02M | -39.70M | EBITDA |
-102.61M | -98.19M | -70.94M | -47.21M | -36.55M | Net Income Common Stockholders |
-137.73M | -134.10M | -115.03M | -83.45M | -69.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
55.87M | 120.74M | 6.67K | 128.32M | 60.49M | Total Assets |
174.68M | 241.62M | 152.49M | 193.01M | 118.98M | Total Debt |
30.78M | 19.94M | 7.41M | 5.33M | 10.59M | Net Debt |
-12.72M | -55.64M | 7.41M | -122.98M | -49.91M | Total Liabilities |
161.24M | 127.15M | 9.71M | 67.30M | 35.79M | Stockholders Equity |
13.45M | 114.47M | 142.78M | 125.71M | 83.19M |
Cash Flow | Free Cash Flow | |||
-94.37M | -105.85M | -11.08M | -48.34M | -46.38M | Operating Cash Flow |
-89.06M | -97.30M | -345.73K | -42.59M | -39.27M | Investing Cash Flow |
28.35M | -57.91M | 9.00K | -5.75M | -6.59M | Financing Cash Flow |
30.21M | 148.19M | 50.55M | 116.02M | 44.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $10.14M | 7.69 | 3.53% | ― | 4.07% | ― | |
63 Neutral | $4.26B | 11.28 | 5.43% | 215.24% | 4.12% | -8.73% | |
47 Neutral | $47.86M | ― | -182.17% | ― | -20.82% | 25.63% | |
43 Neutral | $49.87M | ― | -25.01% | ― | 0.05% | -99.92% | |
39 Underperform | $153.14M | ― | -38.46% | ― | -34.12% | -3803.38% | |
36 Underperform | $12.35M | ― | -116.08% | ― | -100.00% | 24.94% |
On March 20, 2025, LanzaTech Global expanded its Board of Directors by appointing Jill Frizzley as a Class III director, who will serve on the Strategic Committee. This appointment is part of LanzaTech’s broader strategic measures, which have impacted its management resources, leading to a delay in filing its 2024 Annual Report and postponing its earnings disclosures and conference call. The company anticipates filing within the extension period and is focused on deploying its technology globally while improving its cost structure.
On March 4, 2025, LanzaTech Global announced strategic actions to transition from an innovation hub to a profitable enterprise, including the evaluation of partnership opportunities for its LanzaTech Nutritional Protein and the spin-off of its synthetic biology platform, LanzaX. The company aims to streamline operations, reduce annual cash operating expenses by approximately $30 million, and focus on high-impact commercial projects, such as waste-based ethanol-to-SAF facilities in the UK and EU. Additionally, LanzaTech rescheduled its fourth quarter and full-year 2024 earnings call to March 31, 2025, to align with its Annual Report filing.
LanzaTech Global, Inc. and Brookfield Asset Management Inc. have entered into a Loan Agreement to further develop and construct facilities using LanzaTech’s carbon capture technology. The agreement, effective February 14, 2025, replaces a previous equity agreement and outlines a $60 million loan from Brookfield to LanzaTech, with specific repayment terms and restrictions on LanzaTech’s activities. This collaboration underscores the strong partnership between the two companies and aims to advance LanzaTech’s technological capabilities in the carbon capture industry.